Sorafenib-d3

CAS No. 1130115-44-4

Sorafenib-d3( Sorafenib (D3) | Bay 43-9006 (D3) )

Catalog No. M26821 CAS No. 1130115-44-4

Sorafenib-d3 is a deuterium-labeled Sorafenib which is a multikinase inhibitor(IC50s: 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 202 In Stock
5MG 188 In Stock
10MG 339 In Stock
25MG 561 In Stock
50MG 796 In Stock
100MG 1070 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sorafenib-d3
  • Note
    Research use only, not for human use.
  • Brief Description
    Sorafenib-d3 is a deuterium-labeled Sorafenib which is a multikinase inhibitor(IC50s: 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively).
  • Description
    Sorafenib-d3 is a deuterium-labeled Sorafenib which is a multikinase inhibitor(IC50s: 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Sorafenib (D3) | Bay 43-9006 (D3)
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    TGFβ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1130115-44-4
  • Formula Weight
    467.84
  • Molecular Formula
    C21H16ClF3N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (213.75 mM)
  • SMILES
    O(C=1C=C(C(NC([2H])([2H])[2H])=O)N=CC1)C2=CC=C(NC(NC3=CC(C(F)(F)F)=C(Cl)C=C3)=O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bowen C, et al. Mitochondrial-related effects of pentabromophenol, tetrabromobisphenol A, and triphenyl phosphate on murine BV-2 microglia cells. Chemosphere. 2020 Sep;255:126919.
molnova catalog
related products
  • Lonafarnib

    Lonafarnib is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Phase 3.

  • BRAF inhibitor

    A potent Raf inhibitor.

  • Effusanin A

    Effusanin A has antibacterial activity. It exhibits DNA-damaging activity in assay which employed DNA-repair deficient (RAD 52Y) and repairs proficient (RAD +) yeast strains. Effusanin A shows inhibitory effects on DU145 cells with IC50 value of 3.16 μM, and LoVo cells with IC50 value of 3.02 μM.